These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 37406982

  • 21. Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of Alzheimer's disease.
    Liu W, Wu L, Liu W, Tian L, Chen H, Wu Z, Wang N, Liu X, Qiu J, Feng X, Xu Z, Jiang X, Zhao Q.
    Eur J Med Chem; 2022 Nov 15; 242():114689. PubMed ID: 36007469
    [Abstract] [Full Text] [Related]

  • 22. Discovery of Multitarget-Directed Ligands from Piperidine Alkaloid Piperine as a Cap Group for the Management of Alzheimer's Disease.
    Bhanukiran K, Singh SK, Singh R, Kumar A, Hemalatha S.
    ACS Chem Neurosci; 2023 Aug 02; 14(15):2743-2760. PubMed ID: 37433759
    [Abstract] [Full Text] [Related]

  • 23. Identification of ovalbumin-derived peptides as multi-target inhibitors of AChE, BChE, and BACE1.
    Yu Z, Dong W, Wu S, Shen J, Zhao W, Ding L, Liu J, Zheng F.
    J Sci Food Agric; 2020 Apr 02; 100(6):2648-2655. PubMed ID: 31997357
    [Abstract] [Full Text] [Related]

  • 24. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
    Ali MY, Jannat S, Edraki N, Das S, Chang WK, Kim HC, Park SK, Chang MS.
    Chem Biol Interact; 2019 Aug 25; 309():108707. PubMed ID: 31194956
    [Abstract] [Full Text] [Related]

  • 25. Design and synthesis of phenoxy methyl-oxadiazole compounds against Alzheimer's disease.
    Evren AE, Nuha D, Özkan BNS, Kahraman Ç, Gönülalan EM, Yurttaş L.
    Arch Pharm (Weinheim); 2024 Aug 25; 357(8):e2400115. PubMed ID: 38657203
    [Abstract] [Full Text] [Related]

  • 26. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
    Lee S, Youn K, Lim G, Lee J, Jun M.
    Molecules; 2018 Jun 22; 23(7):. PubMed ID: 29932100
    [Abstract] [Full Text] [Related]

  • 27. Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer's agents.
    Iraji A, Nikfar P, Nazari Montazer M, Karimi M, Edraki N, Saeedi M, Mirfazli SS.
    Sci Rep; 2024 Sep 10; 14(1):21115. PubMed ID: 39256495
    [Abstract] [Full Text] [Related]

  • 28. New Benzamides as Multi-Targeted Compounds: A Study on Synthesis, AChE and BACE1 Inhibitory Activity and Molecular Docking.
    Drozdowska D, Maliszewski D, Wróbel A, Ratkiewicz A, Sienkiewicz M.
    Int J Mol Sci; 2023 Oct 04; 24(19):. PubMed ID: 37834347
    [Abstract] [Full Text] [Related]

  • 29. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
    Nuthakki VK, Yadav Bheemanaboina RR, Bharate SB.
    Bioorg Chem; 2021 Feb 04; 107():104568. PubMed ID: 33418314
    [Abstract] [Full Text] [Related]

  • 30. Exploring the Benzazoles Derivatives as Pharmacophores for AChE, BACE1, and as Anti-Aβ Aggregation to Find Multitarget Compounds against Alzheimer's Disease.
    Rosales Hernández MC, Olvera-Valdez M, Velazquez Toledano J, Mendieta Wejebe JE, Fragoso Morales LG, Cruz A.
    Molecules; 2024 Oct 09; 29(19):. PubMed ID: 39407708
    [Abstract] [Full Text] [Related]

  • 31. Anti-Alzheimer's disease activity of compounds from the root bark of Morus alba L.
    Kuk EB, Jo AR, Oh SI, Sohn HS, Seong SH, Roy A, Choi JS, Jung HA.
    Arch Pharm Res; 2017 Mar 09; 40(3):338-349. PubMed ID: 28093699
    [Abstract] [Full Text] [Related]

  • 32. 4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease.
    Komatović K, Matošević A, Terzić-Jovanović N, Žunec S, Šegan S, Zlatović M, Maraković N, Bosak A, Opsenica DM.
    Pharmaceutics; 2022 Jun 20; 14(6):. PubMed ID: 35745878
    [Abstract] [Full Text] [Related]

  • 33. Multifunctional Donepezil Analogues as Cholinesterase and BACE1 Inhibitors.
    Green KD, Fosso MY, Garneau-Tsodikova S.
    Molecules; 2018 Dec 08; 23(12):. PubMed ID: 30544832
    [Abstract] [Full Text] [Related]

  • 34. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S, Prajapati SK, Majumdar S, Raza MK, Gabr MT, Kumar S, Pal K, Rashid H, Kumar S, Krishnamurthy S, Hoda N.
    Eur J Med Chem; 2021 Apr 05; 215():113224. PubMed ID: 33582578
    [Abstract] [Full Text] [Related]

  • 35. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
    Košak U, Strašek N, Knez D, Jukič M, Žakelj S, Zahirović A, Pišlar A, Brazzolotto X, Nachon F, Kos J, Gobec S.
    Eur J Med Chem; 2020 Jul 01; 197():112282. PubMed ID: 32380361
    [Abstract] [Full Text] [Related]

  • 36. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF, Kovaleva NV, Boltneva NP, Lushchekina SV, Rudakova EV, Stupina TS, Terentiev AA, Serkov IV, Proshin AN, Radchenko EV, Palyulin VA, Bachurin SO, Richardson RJ.
    Bioorg Chem; 2020 Jan 01; 94():103387. PubMed ID: 31735356
    [Abstract] [Full Text] [Related]

  • 37. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP, Shankar G, Jahan S, Singh G, Kumar N, Barik A, Upadhyay P, Singh L, Kamble K, Singh GK, Tiwari S, Garg P, Gupta S, Modi G.
    Bioorg Med Chem; 2021 Sep 15; 46():116385. PubMed ID: 34481338
    [Abstract] [Full Text] [Related]

  • 38. Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3β level targeting Alzheimer's disease.
    Noori M, Dastyafteh N, Safapoor S, Khalili Ghomi M, Tanideh R, Zomorodian K, Hamedifar H, Dara M, Zare S, Irajie C, Javanshir S, Rastegar H, Panahi N, Larijani B, Mahdavi M, Hajimiri MH, Iraji A.
    Int J Biol Macromol; 2023 Dec 31; 253(Pt 7):127392. PubMed ID: 37827412
    [Abstract] [Full Text] [Related]

  • 39. Kinetics and Molecular Docking Studies of 6-Formyl Umbelliferone Isolated from Angelica decursiva as an Inhibitor of Cholinesterase and BACE1.
    Ali MY, Seong SH, Reddy MR, Seo SY, Choi JS, Jung HA.
    Molecules; 2017 Sep 24; 22(10):. PubMed ID: 28946641
    [Abstract] [Full Text] [Related]

  • 40. Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice.
    Viayna E, Coquelle N, Cieslikiewicz-Bouet M, Cisternas P, Oliva CA, Sánchez-López E, Ettcheto M, Bartolini M, De Simone A, Ricchini M, Rendina M, Pons M, Firuzi O, Pérez B, Saso L, Andrisano V, Nachon F, Brazzolotto X, García ML, Camins A, Silman I, Jean L, Inestrosa NC, Colletier JP, Renard PY, Muñoz-Torrero D.
    J Med Chem; 2021 Jan 14; 64(1):812-839. PubMed ID: 33356266
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.